142 related articles for article (PubMed ID: 29777446)
1. The degree of HIV-1 amino acid variability is strictly related to different disease progression rates.
Scutari R; Faieta M; D'Arrigo R; Fabeni L; Mussini C; Cossarizza A; Casoli C; Perno CF; Svicher V; Alteri C; Aquaro S
Virus Genes; 2018 Aug; 54(4):493-501. PubMed ID: 29777446
[TBL] [Abstract][Full Text] [Related]
2. Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children.
Casartelli N; Di Matteo G; Argentini C; Cancrini C; Bernardi S; Castelli G; Scarlatti G; Plebani A; Rossi P; Doria M
AIDS; 2003 Jun; 17(9):1291-301. PubMed ID: 12799550
[TBL] [Abstract][Full Text] [Related]
3. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
[TBL] [Abstract][Full Text] [Related]
4. Relative dominance of Env-gp41-specific cytotoxic T lymphocytes responses in HIV-1 advanced infection.
Zhuang Y; Sun Y; Zhai S; Huang D; Zhao S; Wang S; Kang W; Li X; Walker BD; Altfeld M; Yu XG
Curr HIV Res; 2008 May; 6(3):239-45. PubMed ID: 18473787
[TBL] [Abstract][Full Text] [Related]
5. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
[TBL] [Abstract][Full Text] [Related]
6. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
7. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
[TBL] [Abstract][Full Text] [Related]
8. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
[TBL] [Abstract][Full Text] [Related]
9. Conserved neutralizing epitopes of HIV type 1 CRF01_AE against primary isolates in long-term nonprogressors.
Sreepian A; Srisurapanon S; Horthongkham N; Tunsupasawasdikul S; Kaoriangudom S; Khusmith S; Sutthent R
AIDS Res Hum Retroviruses; 2004 May; 20(5):531-42. PubMed ID: 15186528
[TBL] [Abstract][Full Text] [Related]
10. Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.
Menzo S; Sampaolesi R; Vicenzi E; Santagostino E; Liuzzi G; Chirianni A; Piazza M; Cohen OJ; Bagnarelli P; Clementi M
AIDS; 1998 Jun; 12(9):985-97. PubMed ID: 9662194
[TBL] [Abstract][Full Text] [Related]
11. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.
Navis M; Schellens IM; van Swieten P; Borghans JA; Miedema F; Kootstra NA; van Baarle D; Schuitemaker H
J Infect Dis; 2008 Mar; 197(6):871-9. PubMed ID: 18279072
[TBL] [Abstract][Full Text] [Related]
12. Nef mutations in long-term non-progressors from former plasma donors infected with HIV-1 subtype B in China.
Wang SH; Xing H; He X; Zhu FX; Meng ZF; Ruan YH; Shao YM
Biomed Environ Sci; 2008 Dec; 21(6):485-91. PubMed ID: 19263804
[TBL] [Abstract][Full Text] [Related]
13. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus.
Nehete PN; Lewis DE; Tang DN; Pollack MS; Sastry KJ
Viral Immunol; 1998; 11(3):119-29. PubMed ID: 9918403
[TBL] [Abstract][Full Text] [Related]
14. Statistical correlation of nonconservative substitutions of HIV gp41 variable amino acid residues with the R5X4 HIV-1 phenotype.
Pacheco-Martínez E; Figueroa-Medina E; Villarreal C; Cocho G; Medina-Franco JL; Méndez-Lucio O; Huerta L
Virol J; 2016 Feb; 13():28. PubMed ID: 26879054
[TBL] [Abstract][Full Text] [Related]
15. Conserved domains of subtype C nef from South African HIV type 1-infected individuals include cytotoxic T lymphocyte epitope-rich regions.
Mashishi T; Loubser S; Hide W; Hunt G; Morris L; Ramjee G; Abdool-Karim S; Williamson C; Gray CM
AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1681-7. PubMed ID: 11779357
[TBL] [Abstract][Full Text] [Related]
16. Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission.
Ramakrishnan R; Mehta R; Sundaravaradan V; Davis T; Ahmad N
Retrovirology; 2006 Jul; 3():42. PubMed ID: 16820061
[TBL] [Abstract][Full Text] [Related]
17. Resistance mutations and CTL epitopes in archived HIV-1 DNA of patients on antiviral treatment: toward a new concept of vaccine.
Papuchon J; Pinson P; Lazaro E; Reigadas S; Guidicelli G; Taupin JL; Neau D; Fleury H;
PLoS One; 2013; 8(7):e69029. PubMed ID: 23874854
[TBL] [Abstract][Full Text] [Related]
18. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
[TBL] [Abstract][Full Text] [Related]
19. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1).
da Silva J; Hughes AL
Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432
[TBL] [Abstract][Full Text] [Related]
20. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.
Bruce C; Clegg C; Featherstone A; Smith J; Biryahawaho B; Downing R; Oram J
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1543-50. PubMed ID: 7888209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
